Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by bfwon Jul 16, 2021 10:13am
109 Views
Post# 33558852

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Financial and others

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Financial and others
Hmm...so GLPG's inferior stock performance can be blamed on the FDA ;)

Oh well, as long as you are happy being down about 70% in a year or back to 5 year lows.

For reference, TH was $2.55 5 years ago.

I'm not happy with that performance either but at least it is up on a 5 year basis.

Perhaps time to give Paul a chance to execute.

bfw

canadapiet wrote: Hahaha, 

bad comparisan mister bfw!!! 

GLPG was "screwed" by the FDA with their RA Filgotinib. It is approved in
Europe and Japan, so give me the reason why not in the US !
Oh, don't, i know allready, ABBV was in the room .............!

TH lied in the past and with new management it is more of the same! Glad
i sold my 9.500 shares for 4,80 CAD ! 
Mister P L says they are in a strong position....., maybe the same strong
position when they had to do the wonderful O O............
What L. Gibson told me on the call was "astonishing" and an example of
"bad management". "In the past we did not do an offering at a much higher
price because we did not need the money.....????!!!!!

Oh my......., then GLPG management was way more clever!!! They have 
5 B !!!!!!!!!!!!! cash on hand!! 


Good luck sir! 

bfw
 - (7/16/2021 9:29:05 AM) 
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Financial and others
Which company has worse management? THTX or GLPG?

The latter had hihgly touted management but has sunk like the provervial rock. Down about 75% since its peak. Ouch!

bfw






<< Previous
Bullboard Posts
Next >>